{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:01:25Z","timestamp":1786323685309,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.amjcard.2013.10.026","type":"journal-article","created":{"date-parts":[[2013,11,9]],"date-time":"2013-11-09T09:45:14Z","timestamp":1383990314000},"page":"446-451","source":"Crossref","is-referenced-by-count":8,"title":["Effect of Rosuvastatin Therapy on Troponin I Release Following Percutaneous Coronary Intervention in Nonemergency Patients (from the TIP 3 Study)"],"prefix":"10.1016","volume":"113","clinical-trial-number":[{"clinical-trial-number":"nct01378715","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Josef","family":"Veselka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"H\u00e1jek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavol","family":"Toma\u0161ov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tesa\u0159","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Br\u016fhov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Mat\u011bjovi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Branny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Studen\u010dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zem\u00e1nek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2013.10.026_bib1","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2013.10.026_bib2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/CIRCULATIONAHA.111.041160","volume":"125","author":"Bonaca","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2013.10.026_bib3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ccd.22160","article-title":"The impact of micro troponin leak on long-term outcomes following elective percutaneous coronary intervention","volume":"74","author":"Milani","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2013.10.026_bib4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/01.CIR.0000137828.06205.87","article-title":"Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention. Results from the ARMYDA (Atorvastatin for Reduction MYocardial Damage during Angioplasty) study","volume":"110","author":"Pasceri","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2013.10.026_bib5","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jacc.2007.02.025","article-title":"Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention. Results of the ARMYDA-ACS randomized trial","volume":"49","author":"Patti","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2013.10.026_bib6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jacc.2009.05.028","article-title":"Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE randomized trial","volume":"54","author":"DiSciascio","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2013.10.026_bib7","first-page":"659","article-title":"Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome","volume":"122","author":"Jia","year":"2009","journal-title":"Chin Med J"},{"key":"10.1016\/j.amjcard.2013.10.026_bib8","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.jacc.2009.07.005","article-title":"Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction","volume":"54","author":"Briguori","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2013.10.026_bib9","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.ehj.2004.07.017","article-title":"Statin administration before percutaneous coronary intervention: impact on\u00a0periprocedural myocardial infarction","volume":"25","author":"Briguori","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2013.10.026_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijcard.2010.04.052","article-title":"12-Month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome","volume":"146","author":"Yun","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2013.10.026_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10557-010-6224-1","article-title":"Prevention of peri-procedural myocardial injury using a single high dose of rosuvastatin","volume":"24","author":"Cay","year":"2010","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.amjcard.2013.10.026_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.amjcard.2008.08.052","article-title":"Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"103","author":"Lev","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2013.10.026_bib13","first-page":"115","article-title":"Impact of statin therapy on coronary intervention for non-ST elevation acute coronary syndrome with decreased low-density lipoprotein cholesterol","volume":"49","author":"Hara","year":"2007","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.amjcard.2013.10.026_bib14","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/CIRCULATIONAHA.110.002451","article-title":"Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies","volume":"123","author":"Patti","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2013.10.026_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00380-005-0885-x","article-title":"Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention","volume":"21","author":"Veselka","year":"2006","journal-title":"Heart Vessels"},{"key":"10.1016\/j.amjcard.2013.10.026_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1540-8183.2011.00709.x","article-title":"Effect of statin therapy prior to percutaneous coronary intervention","volume":"25","author":"Luo","year":"2012","journal-title":"J\u00a0Interven Cardiol"},{"key":"10.1016\/j.amjcard.2013.10.026_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.amjcard.2009.04.048","article-title":"Effect of two-day atorvastatin pretreatment on incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention","volume":"104","author":"Veselka","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2013.10.026_bib18","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.amjcard.2010.12.040","article-title":"Effect of two-day atorvastatin pretreatment on long-term outcome of patients with stable angina pectoris undergoing elective percutaneous coronary intervention","volume":"107","author":"Veselka","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2013.10.026_bib19","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.amjcard.2012.06.052","article-title":"Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous intervention","volume":"110","author":"Gordin","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2013.10.026_bib20","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/j.ijcard.2013.03.002","article-title":"Effect of seven-day atorvastatin pretreatment on the incidence of peri-procedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study","volume":"168","author":"Zem\u00e1nek","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2013.10.026_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2013.10.026_bib22","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1056\/NEJM200504143521525","article-title":"Distribution of C-reactive protein values in the United States","volume":"352","author":"Woloshin","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2013.10.026_bib23","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/bmj.322.7292.989","article-title":"Interpreting results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?","volume":"322","author":"Freemantle","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2013.10.026_bib24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/FJC.0b013e31829be05b","article-title":"Protection by atorvastatin pretreatment in patients undergoing primary percutaneous coronary intervention is associated with the lower levels of oxygen free radicals","volume":"62","author":"Chen","year":"2013","journal-title":"J\u00a0Cardiovasc Pharmacol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914913021565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914913021565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T18:55:40Z","timestamp":1539197740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914913021565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0002914913021565"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2013.10.026","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}